|
FR2850282B1
(fr)
|
2003-01-27 |
2007-04-06 |
Jerome Asius |
Implant injectable a base de ceramique pour le comblement de rides, depressions cutanees et cicatrices, et sa preparation
|
|
CN102144961A
(zh)
*
|
2003-09-18 |
2011-08-10 |
参天制药株式会社 |
经巩膜递送
|
|
US8591885B2
(en)
*
|
2004-04-30 |
2013-11-26 |
Allergan, Inc. |
Carbonic anhydrase inhibitor sustained release intraocular drug delivery systems
|
|
EP2594259A1
(en)
|
2004-08-04 |
2013-05-22 |
Brookwood Pharmaceuticals, Inc. |
Methods for manufacturing delivery devices and devices thereof
|
|
US9993558B2
(en)
|
2004-10-01 |
2018-06-12 |
Ramscor, Inc. |
Sustained release eye drop formulations
|
|
KR101341359B1
(ko)
*
|
2004-10-01 |
2013-12-13 |
램스코르 인코포레이티드 |
편리하게 이식가능한 서방형 약물 조성물
|
|
EP2329838A3
(fr)
*
|
2004-11-22 |
2013-02-13 |
Centre National de la Recherche Scientifique |
Nétrine 4 mutée, ses fragments et leur utilisation comme médicaments
|
|
US8663639B2
(en)
|
2005-02-09 |
2014-03-04 |
Santen Pharmaceutical Co., Ltd. |
Formulations for treating ocular diseases and conditions
|
|
EP1853259A1
(en)
|
2005-02-09 |
2007-11-14 |
Macusight, Inc. |
Formulations for ocular treatment
|
|
WO2007019427A2
(en)
*
|
2005-08-08 |
2007-02-15 |
Massachusetts Eye & Ear Infirmary |
Methods and compositions for preserving the viability of photoreceptor cells
|
|
US20070212397A1
(en)
*
|
2005-09-15 |
2007-09-13 |
Roth Daniel B |
Pharmaceutical delivery device and method for providing ocular treatment
|
|
WO2007076462A2
(en)
*
|
2005-12-22 |
2007-07-05 |
Oakwood Laboratories, Llc |
Sublimable sustained release delivery system and method of making same
|
|
US7756524B1
(en)
|
2006-01-31 |
2010-07-13 |
Nextel Communications Inc. |
System and method for partially count-based allocation of vocoder resources
|
|
JP5367692B2
(ja)
|
2006-02-08 |
2013-12-11 |
タイレックス・インコーポレイテッド |
一時的補剛メッシュ補綴具
|
|
US8591531B2
(en)
|
2006-02-08 |
2013-11-26 |
Tyrx, Inc. |
Mesh pouches for implantable medical devices
|
|
EP2001438A2
(en)
|
2006-02-09 |
2008-12-17 |
Macusight, Inc. |
Stable formulations, and methods of their preparation and use
|
|
US20090140212A1
(en)
*
|
2006-02-24 |
2009-06-04 |
Friedman Joel M |
Electron Transfer Through Glassy Matrices
|
|
EP2001466B1
(en)
|
2006-03-23 |
2016-01-06 |
Santen Pharmaceutical Co., Ltd |
Low-dose rapamycin for the treatment of vascular permeability-related diseases
|
|
US20070265329A1
(en)
*
|
2006-05-12 |
2007-11-15 |
Devang Shah T |
Methods for the prevention of acute and delayed chemotherapy-induced nausea and vomiting (CINV)
|
|
EP1864667B1
(en)
*
|
2006-06-01 |
2013-09-04 |
Novagali Pharma S.A. |
Use of prodrugs for ocular intravitreous administration
|
|
NZ574524A
(en)
|
2006-08-09 |
2011-07-29 |
Intarcia Therapeutics Inc |
Piston assembly for positioning lumen of a reservoir for an osmotic delivery having a columnar body and a spring
|
|
RU2009110257A
(ru)
*
|
2006-08-23 |
2010-09-27 |
Новартис АГ (CH) |
Применение ингибиторов ркс, прежде всего производных индолилмалеимида для лечения глазных заболеваний
|
|
US8821943B2
(en)
*
|
2006-09-12 |
2014-09-02 |
Board Of Regents Of The University Of Nebraska |
Methods and compositions for targeted delivery of therapeutic agents
|
|
US20080138350A1
(en)
*
|
2006-10-20 |
2008-06-12 |
Bennett Michael D |
Process for use of fluoroquinolones to reduce or modulate inflammation due to eye disease or ophthalmic surgery
|
|
CA2667890C
(en)
*
|
2006-10-31 |
2015-01-27 |
Surmodics Pharmaceuticals, Inc. |
Spheronized polymer particles
|
|
US9023114B2
(en)
|
2006-11-06 |
2015-05-05 |
Tyrx, Inc. |
Resorbable pouches for implantable medical devices
|
|
AU2007335406B2
(en)
|
2006-12-18 |
2012-09-13 |
Takeda Pharmaceutical Company Limited |
Sustained-release composition and method for producing the same
|
|
KR20090118999A
(ko)
*
|
2007-03-07 |
2009-11-18 |
아브락시스 바이오사이언스, 엘엘씨 |
항암제로서 라파마이신 및 알부민을 포함하는 나노입자
|
|
US8642067B2
(en)
|
2007-04-02 |
2014-02-04 |
Allergen, Inc. |
Methods and compositions for intraocular administration to treat ocular conditions
|
|
US20080265343A1
(en)
*
|
2007-04-26 |
2008-10-30 |
International Business Machines Corporation |
Field effect transistor with inverted t shaped gate electrode and methods for fabrication thereof
|
|
DK2155188T3
(da)
*
|
2007-06-01 |
2013-11-04 |
Abraxis Bioscience Llc |
Fremgangsmåder og sammensætninger til behandling af tilbagevendende kræft
|
|
US20080317805A1
(en)
*
|
2007-06-19 |
2008-12-25 |
Mckay William F |
Locally administrated low doses of corticosteroids
|
|
US9827210B2
(en)
*
|
2007-06-29 |
2017-11-28 |
Phovitreal Pty Ltd |
Treatment or prophylaxis of a neurological or neuropsychiatric disorders via ocular administration
|
|
KR100882817B1
(ko)
*
|
2007-07-20 |
2009-02-10 |
숙명여자대학교산학협력단 |
보툴리늄 독소를 유효성분으로 포함하는 지방세포 생착증진용 약학적 조성물
|
|
US8124601B2
(en)
*
|
2007-11-21 |
2012-02-28 |
Bristol-Myers Squibb Company |
Compounds for the treatment of Hepatitis C
|
|
US20110097408A1
(en)
*
|
2007-12-10 |
2011-04-28 |
O'malley Bert W |
Chitosan-based matrices and uses thereof
|
|
US8728528B2
(en)
|
2007-12-20 |
2014-05-20 |
Evonik Corporation |
Process for preparing microparticles having a low residual solvent volume
|
|
WO2009089845A1
(de)
|
2008-01-18 |
2009-07-23 |
Horst Kief |
Mittel zur intraartikulären injektion
|
|
WO2009102467A2
(en)
|
2008-02-13 |
2009-08-20 |
Intarcia Therapeutics, Inc. |
Devices, formulations, and methods for delivery of multiple beneficial agents
|
|
US20090226547A1
(en)
*
|
2008-03-05 |
2009-09-10 |
Gilbard Jeffrey P |
Dietary Supplement For Eye Health
|
|
US9125917B2
(en)
*
|
2008-04-18 |
2015-09-08 |
Warsaw Orthopedic, Inc. |
Fluocinolone formulations in a biodegradable polymer carrier
|
|
US8883768B2
(en)
*
|
2008-04-18 |
2014-11-11 |
Warsaw Orthopedic, Inc. |
Fluocinolone implants to protect against undesirable bone and cartilage destruction
|
|
US9132119B2
(en)
*
|
2008-04-18 |
2015-09-15 |
Medtronic, Inc. |
Clonidine formulation in a polyorthoester carrier
|
|
JP5713897B2
(ja)
*
|
2008-07-16 |
2015-05-07 |
エボニック コーポレイションＥｖｏｎｉｋ Ｃｏｒｐｏｒａｔｉｏｎ |
生理活性ペプチドを含有する微粒子を調製するためのプロセス
|
|
WO2010011597A2
(en)
*
|
2008-07-22 |
2010-01-28 |
Mayo Foundation For Medical Education And Research |
Treatment of obesity and related disorders
|
|
US20110236412A1
(en)
*
|
2008-09-24 |
2011-09-29 |
Stabilitech Ltd. |
Method for Preserving Polypeptides Using a Sugar and Polyethyleneimine
|
|
US20110212127A1
(en)
*
|
2008-09-24 |
2011-09-01 |
Stabilitech Ltd. |
Method for Preserving Polypeptides Using a Sugar and Polyethyleneimine
|
|
WO2010042163A2
(en)
*
|
2008-10-06 |
2010-04-15 |
The Johns Hopkins University |
Quinoline compounds as inhibitors of angiogenesis, human methionine aminopeptidase, and sirt1, and methods of treating disorders
|
|
JP5731980B2
(ja)
|
2008-10-09 |
2015-06-10 |
ラムズコア， インコーポレイテッド |
ドライアイ症候群の処置のための組成物および方法
|
|
AT507187B1
(de)
|
2008-10-23 |
2010-03-15 |
Helmut Dr Buchberger |
Inhalator
|
|
SG173167A1
(en)
|
2009-01-29 |
2011-08-29 |
Forsight Labs Llc |
Posterior segment drug delivery
|
|
US8623395B2
(en)
|
2010-01-29 |
2014-01-07 |
Forsight Vision4, Inc. |
Implantable therapeutic device
|
|
US20120141587A1
(en)
*
|
2009-08-25 |
2012-06-07 |
Dale Yoo |
Compositions and methods for treatment or prevention of post-operative organ or tissue inflammation
|
|
EP2462246B1
(en)
|
2009-09-28 |
2017-09-06 |
Intarcia Therapeutics, Inc |
Rapid establishment and/or termination of substantial steady-state drug delivery
|
|
US20110097380A1
(en)
*
|
2009-10-28 |
2011-04-28 |
Warsaw Orthopedic, Inc. |
Clonidine formulations having antimicrobial properties
|
|
US9101607B2
(en)
|
2010-03-31 |
2015-08-11 |
Stabilitech Ltd. |
Method for preserving alum adjuvants and alum-adjuvanted vaccines
|
|
CN102892424B
(zh)
|
2010-03-31 |
2015-04-01 |
稳定性科技有限公司 |
病毒颗粒的稳定
|
|
EP2552478B1
(en)
|
2010-03-31 |
2016-12-21 |
Stabilitech Ltd. |
Excipients for stabilising viral particles
|
|
DE102010013898A1
(de)
*
|
2010-04-01 |
2011-10-06 |
Acino Ag |
Implantatskanüle mit Implantat und Verfahren zum Befestigen von Implantaten in einer Injektionskanüle
|
|
SI2600812T1
(sl)
|
2010-08-05 |
2021-12-31 |
ForSight Vision4, Inc., |
Naprava za zdravljenje očesa
|
|
JP6111194B2
(ja)
|
2010-08-05 |
2017-04-05 |
フォーサイト・ビジョン フォー・インコーポレーテッド |
組み合わせ薬物送達方法および装置
|
|
SG187730A1
(en)
|
2010-08-05 |
2013-03-28 |
Forsight Vision 4 Inc |
Injector apparatus and method for drug delivery
|
|
CN101972236A
(zh)
*
|
2010-10-13 |
2011-02-16 |
北京诚创康韵医药科技有限公司 |
一种含吡非尼酮的缓释制剂
|
|
WO2012068549A2
(en)
|
2010-11-19 |
2012-05-24 |
Forsight Vision4, Inc. |
Therapeutic agent formulations for implanted devices
|
|
WO2012097258A2
(en)
*
|
2011-01-15 |
2012-07-19 |
The Regents Of The University Of California |
Formulations for the prevention and treatment of wolbachia-related disease
|
|
ES2543312T3
(es)
|
2011-02-11 |
2015-08-18 |
Batmark Limited |
Componente para inhalador
|
|
US20120208755A1
(en)
|
2011-02-16 |
2012-08-16 |
Intarcia Therapeutics, Inc. |
Compositions, Devices and Methods of Use Thereof for the Treatment of Cancers
|
|
HRP20192276T1
(hr)
*
|
2011-06-10 |
2020-05-15 |
Ramscor, Inc. |
Formulacije s produljenim oslobađanjem za dostavu proteina u oko i postupci njihove pripreme
|
|
US10398592B2
(en)
|
2011-06-28 |
2019-09-03 |
Forsight Vision4, Inc. |
Diagnostic methods and apparatus
|
|
EP2739252A4
(en)
|
2011-08-05 |
2015-08-12 |
Forsight Vision4 Inc |
DISPOSAL OF SMALL MOLECULES THROUGH AN IMPLANTABLE THERAPEUTIC DEVICE
|
|
LT2755600T
(lt)
|
2011-09-16 |
2021-04-26 |
Forsight Vision4, Inc. |
Skysčio pakeitimo aparatas
|
|
GB201117233D0
(en)
|
2011-10-05 |
2011-11-16 |
Stabilitech Ltd |
Stabilisation of polypeptides
|
|
US20130190839A1
(en)
*
|
2012-01-20 |
2013-07-25 |
Jane Rapsey |
Drug delivery using a sacrificial host
|
|
US10010448B2
(en)
|
2012-02-03 |
2018-07-03 |
Forsight Vision4, Inc. |
Insertion and removal methods and apparatus for therapeutic devices
|
|
US11596599B2
(en)
|
2012-05-03 |
2023-03-07 |
The Johns Hopkins University |
Compositions and methods for ophthalmic and/or other applications
|
|
KR102310775B1
(ko)
|
2012-05-03 |
2021-10-07 |
칼라 파마슈티컬스, 인크. |
개선된 점막 수송을 나타내는 제약 나노입자
|
|
US10688041B2
(en)
|
2012-05-03 |
2020-06-23 |
Kala Pharmaceuticals, Inc. |
Compositions and methods utilizing poly(vinyl alcohol) and/or other polymers that aid particle transport in mucus
|
|
US9827191B2
(en)
|
2012-05-03 |
2017-11-28 |
The Johns Hopkins University |
Compositions and methods for ophthalmic and/or other applications
|
|
UA116217C2
(uk)
|
2012-10-09 |
2018-02-26 |
Санофі |
Пептидна сполука як подвійний агоніст рецепторів glp1-1 та глюкагону
|
|
US20140105956A1
(en)
*
|
2012-10-11 |
2014-04-17 |
Rupak BANERJEE |
Biodegradable polymer based microimplant for ocular drug delivery
|
|
US9555054B2
(en)
|
2012-11-21 |
2017-01-31 |
University Of Louisville Research Foundation, Inc. |
Compositions and methods for reducing oxidative damage
|
|
MX2015008077A
(es)
|
2012-12-21 |
2015-10-30 |
Sanofi Sa |
Derivados de exendina-4 como agonistas dobles de glp1/gip o trigonal de glp1-gip/glucagon.
|
|
WO2014120866A1
(en)
|
2013-01-31 |
2014-08-07 |
Icon Bioscience, Inc. |
Sustained release formulations for the treatment of intraocular pressure or glaucoma
|
|
WO2014127214A1
(en)
|
2013-02-15 |
2014-08-21 |
Kala Pharmaceuticals, Inc. |
Therapeutic compounds and uses thereof
|
|
CN105189462B
(zh)
|
2013-02-20 |
2017-11-10 |
卡拉制药公司 |
治疗性化合物和其用途
|
|
US9688688B2
(en)
|
2013-02-20 |
2017-06-27 |
Kala Pharmaceuticals, Inc. |
Crystalline forms of 4-((4-((4-fluoro-2-methyl-1H-indol-5-yl)oxy)-6-methoxyquinazolin-7-yl)oxy)-1-(2-oxa-7-azaspiro[3.5]nonan-7-yl)butan-1-one and uses thereof
|
|
US9968603B2
(en)
|
2013-03-14 |
2018-05-15 |
Forsight Vision4, Inc. |
Systems for sustained intraocular delivery of low solubility compounds from a port delivery system implant
|
|
US9526654B2
(en)
|
2013-03-28 |
2016-12-27 |
Forsight Vision4, Inc. |
Ophthalmic implant for delivering therapeutic substances
|
|
AU2014252808A1
(en)
*
|
2013-04-09 |
2015-11-12 |
Cresset Biomolecular Discovery Ltd |
The treatment of inflammatory disorders
|
|
KR102245354B1
(ko)
*
|
2013-05-24 |
2021-04-30 |
아이콘 바이오사이언스, 인크. |
백내장 수술 후 염증에서의 서방출 덱사메타손의 용도
|
|
JP6539274B2
(ja)
|
2013-08-12 |
2019-07-03 |
ファーマシューティカル マニュファクチュアリング リサーチ サービシズ，インコーポレーテッド |
押出成形された即放性乱用抑止性丸剤
|
|
AU2014342042B2
(en)
|
2013-11-01 |
2017-08-17 |
KALA BIO, Inc. |
Crystalline forms of therapeutic compounds and uses thereof
|
|
US9890173B2
(en)
|
2013-11-01 |
2018-02-13 |
Kala Pharmaceuticals, Inc. |
Crystalline forms of therapeutic compounds and uses thereof
|
|
EP3080150B1
(en)
|
2013-12-13 |
2018-08-01 |
Sanofi |
Exendin-4 peptide analogues as dual glp-1/gip receptor agonists
|
|
WO2015086729A1
(en)
|
2013-12-13 |
2015-06-18 |
Sanofi |
Dual glp-1/gip receptor agonists
|
|
EP3080152A1
(en)
|
2013-12-13 |
2016-10-19 |
Sanofi |
Non-acylated exendin-4 peptide analogues
|
|
WO2015086733A1
(en)
|
2013-12-13 |
2015-06-18 |
Sanofi |
Dual glp-1/glucagon receptor agonists
|
|
WO2015095391A1
(en)
|
2013-12-17 |
2015-06-25 |
Pharmaceutical Manufacturing Research Services, Inc. |
Extruded extended release abuse deterrent pill
|
|
US9492444B2
(en)
|
2013-12-17 |
2016-11-15 |
Pharmaceutical Manufacturing Research Services, Inc. |
Extruded extended release abuse deterrent pill
|
|
TW201625670A
(zh)
|
2014-04-07 |
2016-07-16 |
賽諾菲公司 |
衍生自ｅｘｅｎｄｉｎ－４之雙重ｇｌｐ－１／升糖素受體促效劑
|
|
TW201625668A
(zh)
|
2014-04-07 |
2016-07-16 |
賽諾菲公司 |
作為胜肽性雙重ｇｌｐ－１／昇糖素受體激動劑之艾塞那肽－４衍生物
|
|
TW201625669A
(zh)
|
2014-04-07 |
2016-07-16 |
賽諾菲公司 |
衍生自艾塞那肽－４（Ｅｘｅｎｄｉｎ－４）之肽類雙重ＧＬＰ－１／升糖素受體促效劑
|
|
GB201406569D0
(en)
|
2014-04-11 |
2014-05-28 |
Stabilitech Ltd |
Vaccine compositions
|
|
CN106456704A
(zh)
|
2014-04-16 |
2017-02-22 |
Veyx-药物有限公司 |
兽药组合物和其应用
|
|
US9932381B2
(en)
|
2014-06-18 |
2018-04-03 |
Sanofi |
Exendin-4 derivatives as selective glucagon receptor agonists
|
|
WO2016011191A1
(en)
|
2014-07-15 |
2016-01-21 |
Forsight Vision4, Inc. |
Ocular implant delivery device and method
|
|
EP3169315B1
(en)
|
2014-07-17 |
2020-06-24 |
Pharmaceutical Manufacturing Research Services, Inc. |
Immediate release abuse deterrent liquid fill dosage form
|
|
ES2835499T3
(es)
*
|
2014-07-30 |
2021-06-22 |
Massachusetts Eye & Ear Infirmary |
Metotrexato para la vitreorretinopatía proliferativa
|
|
JP2017524034A
(ja)
|
2014-08-08 |
2017-08-24 |
フォーサイト・ビジョン フォー・インコーポレーテッドＦｏｒｓｉｇｈｔ Ｖｉｓｉｏｎ４， Ｉｎｃ． |
受容体型チロシンキナーゼ阻害剤の安定で可溶な製剤およびその調製の方法
|
|
JP2017527611A
(ja)
*
|
2014-08-15 |
2017-09-21 |
ピクサーバイオ コーポレーション |
脊髄損傷を有する患者において炎症を阻害するための組成物、及びそれを使用する方法
|
|
US9889085B1
(en)
|
2014-09-30 |
2018-02-13 |
Intarcia Therapeutics, Inc. |
Therapeutic methods for the treatment of diabetes and related conditions for patients with high baseline HbA1c
|
|
US20160106737A1
(en)
|
2014-10-20 |
2016-04-21 |
Pharmaceutical Manufacturing Research Services, Inc. |
Extended Release Abuse Deterrent Liquid Fill Dosage Form
|
|
GB2535427A
(en)
|
2014-11-07 |
2016-08-24 |
Nicoventures Holdings Ltd |
Solution
|
|
US10500091B2
(en)
|
2014-11-10 |
2019-12-10 |
Forsight Vision4, Inc. |
Expandable drug delivery devices and methods of use
|
|
WO2016130478A1
(en)
|
2015-02-09 |
2016-08-18 |
University Of Louisville Research Foundation, Inc. |
Ophthalmic compositions and methods for reducing oxidative damage to an eye lens
|
|
WO2016148228A1
(ja)
|
2015-03-18 |
2016-09-22 |
参天製薬株式会社 |
徐放性医薬組成物
|
|
MA44390A
(fr)
|
2015-06-03 |
2019-01-23 |
Intarcia Therapeutics Inc |
Systèmes de mise en place et de retrait d'implant
|
|
AR105319A1
(es)
|
2015-06-05 |
2017-09-27 |
Sanofi Sa |
Profármacos que comprenden un conjugado agonista dual de glp-1 / glucagón conector ácido hialurónico
|
|
AR105284A1
(es)
|
2015-07-10 |
2017-09-20 |
Sanofi Sa |
Derivados de exendina-4 como agonistas peptídicos duales específicos de los receptores de glp-1 / glucagón
|
|
GB2542838B
(en)
|
2015-10-01 |
2022-01-12 |
Nicoventures Trading Ltd |
Aerosol provision system
|
|
CN105496947A
(zh)
*
|
2015-11-19 |
2016-04-20 |
苏州桓晨医疗科技有限公司 |
一种药物缓释制剂
|
|
MX2018006234A
(es)
|
2015-11-20 |
2018-08-14 |
Forsight Vision4 Inc |
Estructuras porosas para dispositivos de suministro de medicamentos de liberacion prolongada.
|
|
CN113017981B
(zh)
|
2016-04-05 |
2023-07-25 |
弗赛特影像4股份有限公司 |
药物递送装置
|
|
MA53353A
(fr)
|
2016-05-16 |
2021-06-09 |
Intarcia Therapeutics Inc |
Polypeptides sélectifs pour le récepteur du glucagon et méthodes pour leur utilisation
|
|
USD840030S1
(en)
|
2016-06-02 |
2019-02-05 |
Intarcia Therapeutics, Inc. |
Implant placement guide
|
|
USD860451S1
(en)
|
2016-06-02 |
2019-09-17 |
Intarcia Therapeutics, Inc. |
Implant removal tool
|
|
WO2017218284A1
(en)
*
|
2016-06-13 |
2017-12-21 |
Massachusetts Eye And Ear Infirmary |
Local orbital therapy for thyroid eye disease
|
|
US10682340B2
(en)
|
2016-06-30 |
2020-06-16 |
Durect Corporation |
Depot formulations
|
|
JP7051721B2
(ja)
|
2016-06-30 |
2022-04-11 |
デュレクト コーポレーション |
デポー製剤
|
|
CA3036065A1
(en)
|
2016-09-08 |
2018-03-15 |
Kala Pharmaceuticals, Inc. |
Crystalline forms of therapeutic compounds and uses thereof
|
|
AU2017324713B2
(en)
|
2016-09-08 |
2020-08-13 |
KALA BIO, Inc. |
Crystalline forms of therapeutic compounds and uses thereof
|
|
AU2017324716B2
(en)
|
2016-09-08 |
2020-08-13 |
KALA BIO, Inc. |
Crystalline forms of therapeutic compounds and uses thereof
|
|
TWI773686B
(zh)
|
2016-09-13 |
2022-08-11 |
美商愛力根公司 |
非蛋白梭菌毒素組成物
|
|
WO2018129058A1
(en)
|
2017-01-03 |
2018-07-12 |
Intarcia Therapeutics, Inc. |
Methods comprising continuous administration of a glp-1 receptor agonist and co-adminstration of a drug
|
|
GB2562241B
(en)
|
2017-05-08 |
2022-04-06 |
Stabilitech Biopharma Ltd |
Vaccine compositions
|
|
CN115607358A
(zh)
|
2017-11-21 |
2023-01-17 |
弗赛特影像4股份有限公司 |
用于可扩展端口递送系统的流体交换装置及使用方法
|
|
IL275795B2
(en)
|
2018-01-02 |
2024-12-01 |
Armata Pharmaceuticals Inc |
Medical bacteriophage preparations for the treatment of staphylococcal infection
|
|
EP3750487A4
(en)
|
2018-02-08 |
2020-12-16 |
Terumo Kabushiki Kaisha |
MEDICAL DEVICE AND DEVICE TO PROMOTE ADHESION USER
|
|
US11065003B2
(en)
|
2018-03-19 |
2021-07-20 |
Terumo Kabushiki Kaisha |
Treatment method for joining biological organs
|
|
EP3787611A4
(en)
|
2018-05-01 |
2022-03-09 |
Chibi, Inc. |
LIQUID DEPOT FOR NONINVASIVE DELAYED DELIVERY OF DRUGS TO THE EYE
|
|
CN112423740A
(zh)
|
2018-05-01 |
2021-02-26 |
奇比有限公司 |
用于将药物持续递送至视网膜的滴眼剂制剂和方法
|
|
WO2020067380A1
(ja)
|
2018-09-27 |
2020-04-02 |
テルモ株式会社 |
癒合促進デバイスおよび医療デバイス
|
|
CN112638288B
(zh)
|
2018-09-27 |
2024-03-08 |
泰尔茂株式会社 |
愈合促进设备
|
|
CN113573666A
(zh)
|
2019-03-28 |
2021-10-29 |
泰尔茂株式会社 |
愈合促进器具
|
|
JP7410131B2
(ja)
|
2019-03-28 |
2024-01-09 |
テルモ株式会社 |
癒合促進デバイス
|
|
EP3932440A4
(en)
|
2019-03-28 |
2022-05-04 |
TERUMO Kabushiki Kaisha |
MEDICAL DEVICE
|
|
EP3932439A4
(en)
|
2019-03-28 |
2022-04-27 |
TERUMO Kabushiki Kaisha |
Medical device
|
|
EP4028015A4
(en)
|
2019-09-13 |
2023-11-15 |
Aldeyra Therapeutics, Inc. |
OPHTHALMIC FORMULATIONS OF METHOTREXATE
|
|
US11911499B2
(en)
|
2019-11-07 |
2024-02-27 |
Resurge Therapeutics, Inc. |
System and method for prostate treatment
|
|
CN113262302B
(zh)
*
|
2020-02-17 |
2022-12-09 |
湖州惠中济世生物科技有限公司 |
可注射长效半固体凝胶制剂
|
|
AU2021282983A1
(en)
*
|
2020-06-01 |
2023-02-02 |
Ads Therapeutics Llc |
Topical ophthalmological compositions and methods for treating abnormal angiogenesis
|
|
HUE070328T2
(hu)
*
|
2020-07-07 |
2025-05-28 |
Delsitech Oy |
Szilíciumdioxid-hidrogél kompozit és alkalmazása
|
|
FI20215186A1
(en)
*
|
2021-02-19 |
2022-08-20 |
Rebio Tech Oy |
Compositions for ophthalmic treatment
|
|
US11197819B1
(en)
*
|
2021-04-09 |
2021-12-14 |
Drug Delivery Company, Llc |
Extended release bioabsorbable subcutaneous medicinal dosage delivery implant system
|
|
CN115463217B
(zh)
*
|
2021-06-11 |
2024-03-12 |
深圳埃格林医药有限公司 |
己酸羟孕酮在增强肿瘤治疗效果中的应用
|
|
EP4378493A4
(en)
|
2021-09-03 |
2024-11-27 |
TERUMO Kabushiki Kaisha |
MEDICAL ELEMENT
|
|
USD1033637S1
(en)
|
2022-01-24 |
2024-07-02 |
Forsight Vision4, Inc. |
Fluid exchange device
|
|
US11957654B2
(en)
|
2022-01-29 |
2024-04-16 |
Resurge Therapeutics, Inc. |
Treating benign prostatic hyperplasia
|
|
US11974979B2
(en)
|
2022-01-29 |
2024-05-07 |
Resurge Therapeutics, Inc. |
Treatments for benign prostatic hyperplasia
|
|
US11911385B1
(en)
|
2022-12-14 |
2024-02-27 |
Aldeyra Therapeutics, Inc. |
Methotrexate treatment methods
|
|
WO2025147589A1
(en)
|
2024-01-05 |
2025-07-10 |
Osanni Bio, Inc. |
Implants, compositions, and methods for treating retinal diseases and disorders
|
|
CN118388331B
(zh)
*
|
2024-05-07 |
2025-05-16 |
山东极地医药科技有限公司 |
一种羟基丙酮的生产工艺
|